Xin L - Search Results

1

Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021.

Ma L, Ge ZC, Xin L, Wang YX, Zhang YS, Tang TT, Gao GX, Liu Q, Zhao X, Liu YJ, Qu X; Chinese Society of Breast Surgery. Ma L, et al. Among authors: xin l. Chin Med J (Engl). 2021 Jun 16;134(16):1894-1896. doi: 10.1097/CM9.0000000000001522. Chin Med J (Engl). 2021. PMID: 34133358 Free PMC article. No abstract available.

2

[Interpretation of top issues of the 2013 St Gallen International Expert Consensus].

Liu Y, Xu L, Xin L, Gao G. Liu Y, et al. Among authors: xin l. Zhonghua Wai Ke Za Zhi. 2014 Jun;52(6):401-4. Zhonghua Wai Ke Za Zhi. 2014. PMID: 25219552 Chinese. No abstract available.

3

[Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study].

Xin L, Liu Q, Xu L, Jiang Z, Jiang H, Qin N, Li T, Duan X, Liu Y. Xin L, et al. Zhonghua Yi Xue Za Zhi. 2014 Jul 8;94(26):2018-21. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25312661 Chinese.

4

Intratumoral heterogeneity of HER2 gene amplification in occult breast cancer.

Xin L, Zhang H, Zhang S, Ye J, Li T, Liu Y. Xin L, et al. Chin Med J (Engl). 2014;127(20):3676-7. Chin Med J (Engl). 2014. PMID: 25316250 No abstract available.

5

[Analysis of detecting value of ultrasound and the clinic-pathological features of axillary metastasis in breast cancer].

Xin L, Chen L, Zhang H, Liu Q, Xu L, Wang B, Li T, Duan X, Liu Y. Xin L, et al. Zhonghua Wai Ke Za Zhi. 2014 Dec;52(12):924-8. Zhonghua Wai Ke Za Zhi. 2014. PMID: 25622584 Chinese.

6

Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy.

Liu S, Duan X, Xu L, Xin L, Cheng Y, Liu Q, Ye J, Zhang S, Zhang H, Zhu S, Li T, Liu Y. Liu S, et al. Among authors: xin l. Breast Cancer Res Treat. 2015 Nov;154(2):239-49. doi: 10.1007/s10549-015-3617-7. Epub 2015 Oct 26. Breast Cancer Res Treat. 2015. PMID: 26498019

7

A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.

Xu L, Li JH, Ye JM, Duan XN, Cheng YJ, Xin L, Liu Q, Zhou B, Liu YH. Xu L, et al. Among authors: xin l. Chin Med J (Engl). 2017 Aug 20;130(16):1945-1952. doi: 10.4103/0366-6999.211896. Chin Med J (Engl). 2017. PMID: 28776547 Free PMC article.

8

Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial.

Xiang HY, Liu YH, Zhang H, Zhang S, Xin L, Xu L, Ye JM, Li T, Duan XN, Liu Q. Xiang HY, et al. Among authors: xin l. Chin Med J (Engl). 2019 Dec 20;132(24):2914-2919. doi: 10.1097/CM9.0000000000000548. Chin Med J (Engl). 2019. PMID: 31809316 Free PMC article.

9

Clinicopathological analysis of early-stage breast cancer patients that meet indications for BRCA1/2 genetic testing.

Xiang H, Xin L, Liu Q, Zhang H, Zhang S, Ye J, Cheng Y, Li T, Liu Y, Xu L. Xiang H, et al. Among authors: xin l. Chin J Cancer Res. 2020 Apr;32(2):163-174. doi: 10.21147/j.issn.1000-9604.2020.02.04. Chin J Cancer Res. 2020. PMID: 32410794 Free PMC article.

10

Chinese breast cancer surgery: clinical practice and research.

Xin L, Li JY, Yu ZG, Liu YH. Xin L, et al. Chin Med J (Engl). 2020 Oct 5;133(19):2269-2270. doi: 10.1097/CM9.0000000000000992. Chin Med J (Engl). 2020. PMID: 32769500 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,448 results

Search Page